Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

892
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
892
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

98
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
98
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

1.3K
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Articles You Might Have Missed.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same journal

Botulism Type F, a Rare Type of Botulism that Can Masquerade as a Posterior Fossa Stroke.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same journal

An ACMT Network of Medical Toxicology Clinics (NMTC): A Proposed Collaboration of Medical Toxicologists to Meet National Emergency Preparedness Needs.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same journal

Medical Toxicology is the Overdose Specialty: Implications for the Dimensions and Continuum of Overdose Care.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same journal

Responsiveness of the 2024-2030 ACMT Research Agenda to New Funding Priorities and Research Environment.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same journal

Apixaban Overdose with Massive Bleeding and Anti-Xa Levels.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026

Related Experiment Video

Updated: Mar 14, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

877

Interpretation of Workplace Tests for Cannabinoids.

Ken Kulig1

  • 1Toxicology Associates, Prof LLC, Denver, CO, USA. kkmedtox@msn.com.

Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|October 1, 2016
PubMed
Summary
This summary is machine-generated.

Workplace drug tests for THC metabolites can yield positive results without proving impairment or recent use. Current methods may miss synthetic cannabinoids, and future testing may expand beyond urine analysis.

More Related Videos

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K
In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface
07:05

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface

Published on: June 20, 2025

1.0K

Related Experiment Videos

Last Updated: Mar 14, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

877
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K
In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface
07:05

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface

Published on: June 20, 2025

1.0K

Area of Science:

  • Forensic Toxicology
  • Occupational Health
  • Cannabinoid Science

Background:

  • Workplace drug testing commonly uses urine analysis for inactive THC metabolites.
  • Current testing limitations include inability to confirm impairment or recent use.
  • Detection of synthetic cannabinoids is often not addressed by standard assays.

Purpose of the Study:

  • To review the history and current status of workplace marijuana testing.
  • To discuss the limitations of existing urine drug testing for THC.
  • To explore potential future trends in employee drug screening.

Main Methods:

  • Review of current practices in workplace urine drug testing.
  • Analysis of the scientific basis for detecting THC metabolites.
  • Discussion of emerging synthetic cannabinoids and alternative matrices for drug testing.

Main Results:

  • Positive urine tests for THC metabolites do not correlate with impairment or recent usage.
  • Existing cannabinoid testing often fails to detect synthetic compounds.
  • Urine is the primary matrix, but blood, plasma, oral fluid, and hair are potential future options.

Conclusions:

  • Current workplace drug testing for marijuana metabolites is inadequate for assessing impairment.
  • There is a need for improved testing methods that address synthetic cannabinoids and recent use.
  • Future drug testing protocols may incorporate a broader range of biological matrices.